Skip to main content
12 May 2026
Last updated:
Tuesday 12 May 2026
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
Strategy
Strategy
Capital efficiency -- a new norm
Read more
A new model for Pharma
Read more
A new business model for Pharma
Read more
Silence Therapeutics Plc: Consolidating the RNAi therapeutics space
Read more
For Bioalliance Pharma delivery is the innovation
Read more
Novo Nordisk Biotech Fund
Read more
How consolidation may affect biotech innovation
Read more
How Galapagos built a business from discovery
Read more
How Innate Pharma turned a threat into an opportunity
Read more
How Ablynx uses the llama to create antibodies
Read more
Pagination
Previous page
‹‹
Page 24
Next page
››
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form